Exagen Inc. Announces Select Preliminary 2025 Financial Results
Exagen Inc. Announces Select Preliminary 2025 Financial Results GlobeNewswire January 11, 2026 CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced select preliminary unaudited financial results for the fourth quarter and year ended December 31, 2025, in line with prior financial guidance. Select Preliminary […]